Allergan laying out $90M+ for technology; Former Novartis U.K. site beng repurposed;

@FiercePharma: China's Jiangsu Hansoh plans $3B IPO to tap investor demand. FiercePharmaAsia story | Follow @FiercePharma

@CarlyHFierce: MannKind resolves to find new Afrezza marketing deal after Sanofi bails on partnership. FiercePharmaMarketing story | Follow @CarlyHFierce

> Allergan ($AGN), which has agreed to merge with Pfizer ($PFE), Thursday announced a deal to buy clinical-stage pharmaceutical company Anterios for $90 million and milestones to get its technology to deliver neurotoxins through the skin instead of through injection. Story

> West Sussex County Council will buy a 20-acre former Novartis ($NVS) site in Horsham and turn it into a campus in targeted at attracting life sciences companies. Report

> The American Cancer Society's annual report says the cancer death rate has dropped 23% since its peak in 1991, citing cancer immunotherapies like Opdivo and Keytruda as being promising for trimming the rate further. Report

Medical Device News

@FierceMedDev: KKR, Panasonic form newco Ascensia from Bayer Diabetes buy for $1.1B. Article | Follow @FierceMedDev

@EmilyWFierce: Drug price increases saw 'high water mark' year in 2015: Analysts. FiercePharma story | Follow @EmilyWFierce

@VarunSaxena2: NEA partner outlines challenging med tech VC landscape heading into 2016. Article | Follow @VarunSaxena2

> As NEA buys in, FDA calls for more innovative, affordable and effective hearing aids. Story

> J&J launches consumer health and wellness tech accelerator. Article

> Stealth machine learning startup raises $10M to develop a heart disease detection algorithm. More

Biotech News

@FierceBiotech: The scoop on every new drug approved in 2015. Feature | Follow @FierceBiotech

@JohnCFierce: It's all happening so fast--Alector raises $29M; NextCure launches with $67M; Pfizer leads $15M round for Cortexyme. More | Follow @JohnCFierce

@DamianFierce: Tweeting from HATEFUL 8 intermission & have to say it was jarring when Bruce Dern turned to the camera and said "The 8 of us sure are h8ful." | Follow @DamianFierce

> FDA gets into Rhythm with a 'breakthrough' title for orphan obesity drug. Story

> Allergan spends $90M to get its hands on a topical Botox project. Article

> Another Chinese biopharma lines up for a billion-dollar IPO. Item

CRO News

> PPD spins out its in-house biotech as sale rumors swirl. More

> Charles River spends $585M on WIL Research amid a buyout spree. Article

> UCB taps Evotec to pitch in on drug discovery. Story

> Altasciences rebrands its web of CROs in hopes of standing out. Report

Pharma Manufacturing News

> Baxter recalls more of its saline solutions after a bug was found. Report

> PharMEDium recalls blood pressure control drug due to discoloration/degradation. More

> French developer TxCell signs Belgian CMO for manufacturing deal. Story

> GSK Australia plant to begin using blow-fill-seal technology for vaccines. Item

> Hospira recalls magnesium sulfate injectable due to bad barcoding. Article

Pharma Asia News

> China's Simcere seeks return to public market with $1B HKEx IPO. Story

> Chinese New Year alert in Hong Kong after bird flu fatality. News

> Wanda plans $2.3B hospital investment in China. More

> Precision medicine plan in China may be announced in March. Report

> Takeda bets on microbiome targets in GI push with Enterome deal. Article

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.